Nanobiomedicine, cancer immunotherapy, and autoimmune diseases

The overall objective of our group is to understand nanomedicines-mediated molecular and cellular mechanisms in distinct biomedical applications oriented to cancer and autoimmunity treatment, and to use this knowledge to improve nanomedicines functional design for antitumour and autoinmune disease therapies.

Main specialization

Área de investigación:

Biología y Biomedicina

Disciplina ERC:

LS - LIFE SCIENCES
LS6 Immunity and Infection

Industrial Leadership:

2. Nanotechnologies
2.1. Developing next generation nanomaterials, nanodevices and nanosystems

Societal Challenges:

1. Health, demographic change and wellbeing
1.08. Treating disease